{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T05:26:27Z","timestamp":1706246787931},"reference-count":54,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["contraceptionjournal.org","patient-research.elsevier.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.contraception.2014.03.003","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T18:16:10Z","timestamp":1394820970000},"page":"344-351","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Home-based administration of Sayana\u00ae Press: review and assessment of needs in low-resource settings"],"prefix":"10.1016","volume":"89","author":[{"given":"Bonnie","family":"Keith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Tifft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2014.03.003_bb0005","unstructured":"Medicines and Healthcare Products Regulatory Agency (MHRA). Public assessment report: Sayana Press 104 mg\/0.65 ml suspension for injection. London, UK: MHRA; 2011. Available from: http:\/\/www.mhra.gov.uk\/home\/groups\/par\/documents\/websiteresources\/con126147.pdf."},{"key":"10.1016\/j.contraception.2014.03.003_bb0010","unstructured":"Lande R, Richey C. Global health technical brief: how family planning programs can meet rising demand for injectable contraceptives (based on population reports, series K, no. 6). Baltimore (MD): Johns Hopkins Bloomberg School of Public Health, INFO Project, Center for Communication Programs; 2006. Available from: http:\/\/www.k4health.org\/toolkits\/info-publications\/how-family-planning-programs-can-meet-rising-demand-injectable"},{"key":"10.1016\/j.contraception.2014.03.003_bb0015","unstructured":"United Nations Department of Economic and Social Affairs (UN DESA), Population Division. World contraceptive use 2011 [Internet]. Geneva, Switzerland: UN DESA; 2011 [cited 2013 Mar 11]. Available from: http:\/\/www.un.org\/esa\/population\/publications\/contraceptive2011\/wallchart_front.pdf. Last"},{"key":"10.1016\/j.contraception.2014.03.003_bb0020","unstructured":"World Health Organization, United States Agency for International Development, FHI 360. Community-based health workers can safely and effectively administer injectable contraceptives: conclusions from a technical consultation. Research Triangle Park (NC): FHI 360; 2009. Available from: http:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/WHO_CBD_brief\/en\/index.html."},{"key":"10.1016\/j.contraception.2014.03.003_bb0025","unstructured":"World Health Organization (WHO) Department of Reproductive Health and Research, Johns Hopkins Bloomberg School of Public Health Center for Communication Programs (CCP), and United States Agency for International Development Bureau for Global Health. Family planning: a global handbook for providers. Baltimore (MD) and Geneva, Switzerland: CCP and WHO; 2011. Available from: http:\/\/whqlibdoc.who.int\/publications\/2011\/9780978856373_eng.pdf."},{"key":"10.1016\/j.contraception.2014.03.003_bb0030","unstructured":"World Health Organization (WHO). Selected practice recommendations for contraceptive use: 2008 update. Geneva, Switzerland: WHO; 2008. Available from: http:\/\/whqlibdoc.who.int\/hq\/2008\/WHO_RHR_08.17_eng.pdf."},{"key":"10.1016\/j.contraception.2014.03.003_bb0035","unstructured":"Johns Hopkins Bloomberg School of Public Health Center for Communication Programs (CCP). DMPA at a glance. Baltimore (MD): CCP; 1995. Available from: http:\/\/info.k4health.org\/pr\/k5\/k5dmpa.shtml."},{"key":"10.1016\/j.contraception.2014.03.003_bb0040","unstructured":"Lande R, Richey C. Expanding services for injectables: how family planning programs and providers can meet clients\u2019 needs for injectable contraceptives. Johns Hopkins Bloomberg School of Public Health Population Reports. 2006 Dec;K(6). Available from: http:\/\/www.k4health.org\/toolkits\/info-publications\/expanding-services-injectables-how-family-planning-programs-and-providers."},{"key":"10.1016\/j.contraception.2014.03.003_bb0045","unstructured":"Knowledge for Health (K4Health), Johns Hopkins Bloomberg School of Public Health. Essential knowledge about injectable contraceptives. Baltimore (MD): Johns Hopkins Bloomberg School of Public Health; 2010. Available from: http:\/\/www.k4health.org\/toolkits\/injectables\/essential-knowledge-about-injectables"},{"key":"10.1016\/j.contraception.2014.03.003_bb0050","unstructured":"World Health Organization. WHO statement on hormonal contraception and bone health. Weekly Epidemiological Record. 2005 Sept;80(35):297\u2013304. Available from: http:\/\/whqlibdoc.who.int\/wer\/WHO_WER_2005\/80_297-304%28no35%29.pdf."},{"key":"10.1016\/j.contraception.2014.03.003_bb0055","unstructured":"United States Food and Drug Administration. Approval letter for depo-subQ provera 104 (medroxyprogesterone acetate) injectable suspension [letter]. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2004\/021583s000_APPROV.pdf"},{"issue":"1","key":"10.1016\/j.contraception.2014.03.003_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2004.01.011","article-title":"Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2014.03.003_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"issue":"11","key":"10.1016\/j.contraception.2014.03.003_bb0070","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.clinthera.2004.11.013","article-title":"Suppression of ovulation by a new subcutaneous depot medroxyprogesterone acetate (104 mg\/0.65 mL) contraceptive formulation in Asian women","volume":"26","author":"Toh","year":"2004","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.contraception.2014.03.003_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2009.02.005","article-title":"Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density","volume":"80","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2014.03.003_bb0080","first-page":"93","article-title":"Subcutaneous or intramuscular? Confronting a parenteral administration dilemma","volume":"14","author":"Prettyman","year":"2005","journal-title":"Medsurg Nurs"},{"key":"10.1016\/j.contraception.2014.03.003_bb0085","unstructured":"PATH. The Uniject device. Seattle (WA): PATH; 2009. Available from: http:\/\/www.path.org\/our-work\/uniject.php."},{"key":"10.1016\/j.contraception.2014.03.003_bb0090","unstructured":"PATH [Internet]. Seattle: PATH; c1995\u20132013. Available from: http:\/\/www.path.org\/publications\/files\/TS_inj_safety_ovw.pdf."},{"issue":"2","key":"10.1016\/j.contraception.2014.03.003_bb0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0010-7824(95)00267-7","article-title":"Uniject as a delivery system for the once-a-month injectable contraceptive Cyclofem in Brazil","volume":"53","author":"Bahamondes","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.03.003_bb0100","unstructured":"Sutanto A, Suarnawa IM, Nelson CM, Stewart T, Soewarso TI. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device. Geneva, Switzerland: World Health Organization; 1999. Available from: http:\/\/www.who.int\/bulletin\/archives\/77(2)119.pdf."},{"issue":"1","key":"10.1016\/j.contraception.2014.03.003_bb0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0020-7292(03)00186-3","article-title":"Oxytocin in prefilled Uniject injection devices for managing third-stage labor in Indonesia","volume":"83","author":"Tsu","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.contraception.2014.03.003_bb0110","first-page":"456","article-title":"The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia","volume":"83","author":"Levin","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.contraception.2014.03.003_bb0115","unstructured":"Weil B, Krueger K, Stanback J, Hatzell Hoke T. Provision of injectable contraception services through community-based distribution: an implementation handbook. Raleigh (NC): FHI 360; 2008. Available from: http:\/\/www.fhi360.org\/resource\/provision-injectable-contraception-services-through-community-based-distribution."},{"key":"10.1016\/j.contraception.2014.03.003_bb0120","unstructured":"FHI 360. Best practices in CBD programs in sub-Saharan Africa: lessons learned from research and evaluation. Frontiers in Reproductive Health Program (FRONTIERS), FHI, Advance Africa. Washington, DC: FHI; December 2, 2002. Available from: http:\/\/www.popcouncil.org\/pdfs\/frontiers\/CBD_seminar.pdf"},{"key":"10.1016\/j.contraception.2014.03.003_bb0125","unstructured":"Stanback J, Mbonye A, LeMelle J, Bekiita M, Ssekito, G, Kajura NJ. Final Report: Safety and Feasibility of CBD of Depo Provera in Nakasongola, Uganda. Kampala, Uganda: Family Health International\/Save the Children USA; 2005. Available from: http:\/\/www.hciproject.org\/sites\/default\/files\/Final%20Report%20Safety%20and%20Feasibilty%20of%20Community-Based%20Distribution%20of%20Depo%20Provera.pdf"},{"key":"10.1016\/j.contraception.2014.03.003_bb0130","unstructured":"Khuda B, Kane TT, Phillips JF, editors. Improving the Bangladesh health and family planning programme: lessons learned through operations research. Dhaka, Bangladesh: International Centre for Diarrhoeal Disease Research; 1997. Available from: http:\/\/dspace.icddrb.org\/dspace\/bitstream\/123456789\/2563\/1\/Improving+the+bangladesh+health+and+family+planning+programme,+monograph+5.pdf."},{"key":"10.1016\/j.contraception.2014.03.003_bb0135","unstructured":"World Health Organization (WHO). Working together for health: The world health report. Geneva, Switzerland: WHO; 2006. Available from: http:\/\/www.who.int\/whr\/2006\/en\/index.html."},{"key":"10.1016\/j.contraception.2014.03.003_bb0140","unstructured":"World Health Organization (WHO). Optimizing health worker roles to improve access to key maternal and newborn health interventions through task shifting. Geneva, Switzerland; WHO; 2012. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/77764\/1\/9789241504843_eng.pdf."},{"issue":"3","key":"10.1016\/j.contraception.2014.03.003_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7748\/paed2003.04.15.3.28.c845","article-title":"Teaching home administration of sub-cutaneous methotrexate","volume":"15","author":"Livermore","year":"2003","journal-title":"Paediatr Nurs"},{"issue":"8","key":"10.1016\/j.contraception.2014.03.003_bb0150","doi-asserted-by":"crossref","first-page":"390","DOI":"10.12968\/ijpn.2008.14.8.30774","article-title":"Lay caregivers\u2019 perspectives on injecting subcutaneous medications at home","volume":"14","author":"Israel","year":"2008","journal-title":"Int J Palliat Nurs"},{"issue":"3","key":"10.1016\/j.contraception.2014.03.003_bb0155","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2265.2007.03044.x","article-title":"Home administration of lanreotide Autogel\u00ae by patients with acromegaly, or their partners, is safe and effective","volume":"68","author":"Bevan","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.contraception.2014.03.003_bb0160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.contraception.2013.12.010","article-title":"Perceptions of home and self-injection of Sayana\u00ae Press in Ethiopia: a qualitative study","volume":"89","author":"Keith","year":"2014","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2014.03.003_bb0165","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.contraception.2014.01.022","article-title":"Observational study of the acceptability of Sayana\u00ae Press among intramuscular DMPA users in Uganda and Senegal","volume":"89","author":"Burke","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.03.003_bb0170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.contraception.2011.09.015","article-title":"Self-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptability","volume":"85","author":"Prabhakaran","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.03.003_bb0175","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.contraception.2011.10.002","article-title":"Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception","volume":"85","author":"Cameron","year":"2012","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2014.03.003_bb0180","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.contraception.2012.11.019","article-title":"Self-administration of subcutaneous depot medroxyprogesterone acetate by adolescent women","volume":"88","author":"Williams","year":"2013","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2014.03.003_bb0185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0010-7824(97)00162-5","article-title":"Self-administration with Uniject of the once-a-month injectable Cyclofem","volume":"56","author":"Bahamondes","year":"1997","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2014.03.003_bb0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.contraception.2005.05.020","article-title":"Self-injection of monthly combined hormonal contraceptive","volume":"73","author":"Stanwood","year":"2006","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2014.03.003_bb0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.contraception.2004.12.002","article-title":"The acceptability of self-administration of subcutaneous Depo-Provera","volume":"72","author":"Lakha","year":"2005","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2014.03.003_bb0200","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.contraception.2013.11.008","article-title":"Preference for Sayana\u00ae Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial","volume":"89","author":"Polis","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.03.003_bb0205","series-title":"Injectable contraceptive service delivery provided by volunteer community promoters","author":"Fernandez","year":"1997"},{"issue":"3","key":"10.1016\/j.contraception.2014.03.003_bb0210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2307\/3038206","article-title":"Increasing access to family planning services in rural Mali through community-based distribution","volume":"24","author":"Katz","year":"1998","journal-title":"Int Fam Plan Perspect"},{"key":"10.1016\/j.contraception.2014.03.003_bb0215","unstructured":"Oxford Policy Management. External evaluation of the Lady Health Worker programme. 2009. Oxford, UK: Oxford Policy Management; 2009. Available from: http:\/\/www.opml.co.uk\/sites\/opml\/files\/LHW_%20Management%20Review_1.pdf."},{"issue":"2","key":"10.1016\/j.contraception.2014.03.003_bb0220","first-page":"191","article-title":"Subcutaneous versus intramuscular depot methoxyprogesterone acetate: a comparative review","volume":"2","author":"Simon","year":"2006","journal-title":"Women\u2019s Health"},{"key":"10.1016\/j.contraception.2014.03.003_bb0225","unstructured":"Muller N. Uniject global training experience [internal document]. Seattle (WA); PATH; 2010."},{"issue":"10","key":"10.1016\/j.contraception.2014.03.003_bb0230","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1185\/030079906X132604","article-title":"Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women","volume":"22","author":"Somkuti","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.contraception.2014.03.003_bb0235","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00001610-200509000-00007","article-title":"\u201cI want to do it myself!\u201d Interferon self-injection for children with chronic viral hepatitis","volume":"28","author":"Ott","year":"2005","journal-title":"Gastroenterol Nurs"},{"key":"10.1016\/j.contraception.2014.03.003_bb0240","unstructured":"Pfizer Inc. depo-subQ provera 104\u2122 medroxyprogesterone acetate injectable suspension 104 mg\/0.65 mL: physician information. New York, New York: Pharmacia and Upjohn Company, Division of Pfizer Inc.; 2009. Available from: http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=549."},{"key":"10.1016\/j.contraception.2014.03.003_bb0245","unstructured":"Pfizer Inc. DEPO-PROVERA\u00ae Contraceptive Injection medroxyprogesterone acetate injectable suspension, USP: Physician Information. New York, New York: Pharmacia and Upjohn Company, Division of Pfizer Inc; 2006. Available from: http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=522"},{"key":"10.1016\/j.contraception.2014.03.003_bb0250","series-title":"Sayana\u00ae Press 104 mg\/0.65 ml suspension for injection single-dose container: information for the user [package leaflet]","author":"Pfizer","year":"2012"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2014.03.003_bb0255","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1097\/00042560-199802001-00019","article-title":"Community-based programs for safe disposal of used needles and syringes","volume":"18","author":"Macalino","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.contraception.2014.03.003_bb0260","unstructured":"Richardson F, Chirwa M, Fahnestock M, Bishop M, Emmart P, McHenry B. Community-based distribution of injectable contraceptives in Malawi. Washington, DC: Futures Group International, Health Policy Initiative, Task Order I; 2009. Available from: http:\/\/www.healthpolicyinitiative.com\/Publications\/Documents\/754_1_Community_based_Distribution_of_Injectable_Contraceptives_in_Malawi_FINAL.pdf"},{"key":"10.1016\/j.contraception.2014.03.003_bb0265","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.contraception.2008.07.007","article-title":"Re: Self-administration of injectable contraceptives [letter to the editor]","volume":"78","author":"Stanback","year":"2008","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2014.03.003_bb0270","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.contraception.2014.01.005","article-title":"Operational assessments of Sayana\u00ae Press provision in Senegal and Uganda","volume":"89","author":"Cover","year":"2014","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414001139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414001139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T23:54:40Z","timestamp":1648598080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782414001139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0010782414001139"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2014.03.003","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Home-based administration of Sayana\u00ae Press: review and assessment of needs in low-resource settings","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2014.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}